Response of secretory pathways Ca2+ ATPase gene expression to hyperhomocysteinemia and/or ischemic preconditioning in rat cerebral cortex and hippocampus

General Physiology and Biophysics

Volumn 30, Issue SPECIAL, 2011, Pages

  Pavlikova, Martina ^a   Kovalska, Maria ^a   Tatarkova, Zuzana ^a   Sivonova Kmetova, Monika ^a   Kaplan, Peter ^a   Lehotsky, Jan ^a  

^a University Teaching Hospital in Martin   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); HOMOCYSTEINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; FOREBRAIN; GENE EXPRESSION; HIPPOCAMPUS; HYPERHOMOCYSTEINEMIA; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; RAT; SECRETORY PATHWAY; VERTEBRAL ARTERY STENOSIS; ANIMAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; VASCULARIZATION; WISTAR RAT;

RATTUS;

ANIMALS; CALCIUM-TRANSPORTING ATPASES; CEREBRAL CORTEX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; HYPERHOMOCYSTEINEMIA; ISCHEMIC PRECONDITIONING; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; SECRETORY PATHWAY;

EID: 82255191411     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb-2011-SI1-61     Document Type: Article

References (57)

1. Althausen S., Paschen W. (2000): Homocysteine-induced changes in mRNA levels of genes coding for cytoplasmic- and endo-plasmic reticulum-resident stress proteins in neuronal cell cultures. Mol. Brain Research 84, 32-40 doi:10.1016/S0169-328X(00)00208-4
2. Angelova E. A., Atanassova P. A., Chalakova N. T., Dimitrov B. D. (2008) : Associations between serum selenium and total plasma homocysteine during the acute phase of ischaemic stroke. Eur. Neurol. 60, 298-303 doi:10.1159/000157884
3. Bickler P. E., Fahlman C. S., Gray J., McKleroy W. (2009): Inositol 1,4,5-triphosphate receptors and NAD(P)H mediate Ca2+ signaling required for hypoxic preconditioning of hippocampal neurons. Neuroscience 160, 51-60 doi:10.1016/j.neuroscience.2009.02.013
4. Bottiglieri T. (2005): Homocysteine and folate metabolism in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1103-1112 doi:10.1016/j.pnpbp. 2005.06.021 (Pubitemid 41383509)
5. Danielisová V., Némethová M., Gottlieb M., Burda J. (2005): Changes of endogenous antioxidant enzymes during ischemic tolerance acquisition. Neurochem. Res. 30, 559-565 doi:10.1007/s11064-005-2690-4 (Pubitemid 40933662)
6. Dickhout J. G., Sood S. K., Austin R. C. (2007): Role of endo-plasmic reticulum calcium disequilibria in the mechanism of homocysteine-induced ER stress. Antioxid. Redox Signal. 9, 1863-1873 doi:10.1089/ars.2007.1780 (Pubitemid 47622350)
7. Dionisio N., Jardin I., Salido G. M., Rosado J. A. (2010): Homo-cysteine, intracellular signaling and thrombotic disorders. Curr. Med. Chem. 17, 3109-3119 doi:10.2174/092986710791959783
8. Dirnagl U., Becker K., Meisel A. (2009): Preconditioning and tole-rance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 8, 398-412 doi:10.1016/S1474-4422(09)70054-7
9. Domagała T. B., Undas A., Libura M., Szczeklik A. (1998): Patho-genesis of vascular disease in hyperhomocysteinaemia. J. Cardiovasc. Risk 5, 239-247 doi:10.1097/00043798-199808000-00006 (Pubitemid 29030110)
10. Endres M., Engelhardt B., Koistinaho J., Lindvall O., Meairs S., Mohr J. P., Planas A., Rothwell N., Schwaninger M., Schwab M. E., Vivien D., Wieloch T., Dirnagl U. (2008): Improving outcome afer stroke: overcoming the translational roadblock. Cerebrovasc. Dis. 25, 268-278 doi:10.1159/000118039 (Pubitemid 351450431)
11. Gidday J. M. (2006): Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 7, 437-448 doi:10.1038/nrn1927 (Pubitemid 44012284)
12. Gonatas N. K., Stieber A., Gonatas J. O. (2006): Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J. Neurol. Sci. 246, 21-30 doi:10.1016/j.jns.2006.01.019 (Pubitemid 43815336)
13. Herrmann W., Lorenzl S., Obeid R. (2007): Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurologi- cal and psychiatric disorders-current evidence and preliminary recommendations. Fortschr. Neurol. Psychiatr. 75, 515-527 (Pubitemid 47579752)
14. Hicks S. W., Machamer C. E. (2005): Golgi structure in stress sen-sing and apoptosis. Biochim. Biophys. Acta 1744, 406-414 doi:10.1016/j.bbamcr.2005. 03.002 (Pubitemid 40848258)
15. Jara-Prado A., Ortega-Vazquez A, Martinez-Ruano L, Rios C, Santa-maria A. (2003): Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition. Neurotox. Res. 5, 237-243 doi:10.1007/BF03033381
16. Jiang Z., Hu Z., Zeng L., Lu W., Zhang H., Li T., Xiao H. (2011): Te role of the Golgi apparatus in oxidative stress: is this or- ganelle less significant than mitochondria? Free Radic.Biol. Med. in press doi:10.1016/j.freeradbiomed.2011.01.011
17. Jeremy J. Y., Rowe D., Emsley A. M., Newby A. C. (1999): Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc. Res. 43, 580-594 doi:10.1016/S0008-6363(99)00171-6 (Pubitemid 29369257)
18. Kawada H., Nishiyama C., Takagi A., Tokura T., Nakano N., Maeda K., Mayuzumi N., Ikeda S., Okumura K., Ogawa H. (2005): Transcriptional regulation of ATP2C1 gene by Sp1 and YY1 and reduced function of its promoter in Hailey-Hailey disease keratinocytes. J. Invest. Dermatol. 124, 1206-1214 doi:10.1111/j.0022-202X.2005.23748.x (Pubitemid 40847408)
19. Kruman I. I., Kumaravel T. S., Lohani A., Pedersen W. A., Cutler R. G., Kruman Y., Haughey N., Lee J., Evans M., Mattson M. P. (2002): Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimers disease. J. Ne- urosci. 22, 1752-1762 (Pubitemid 35386293)
20. Lehotský J., Murín R., Strapková A., Uríková A., Tatarková Z., Kaplán P. (2004): Time course of ischemia/reperfusion-indu-ced oxidative modification ofneural proteins in rat forebrain. Gen. Physiol. Biophys. 23, 401-415 (Pubitemid 40352621)
21. Lehotský J., Račay P., Pavlíková M., Tatarková Z., Urban P., Chomo-vá M., Kovalská M., Kaplán P. (2009a): Cross-talk of intrecel-lular calcium stores in the response to neuronal ischemia and ischemic tolerance. Gen. Physiol. Biophys. 28, 104-113
22. Lehotský J., Urban P., Pavlíková M., Tatarková Z., Kaminska B., Kaplán P. (2009b): Molecular mechanisms leading to neu-roprotection/ ischemic tolerance: Effect of preconditioning on the stress reaction of endoplasmic reticulum. Cell. Mol. Neurobiol. 29, 917-925 doi:10.1007/s10571-009-9376-4
23. Lehotský J., Burda J., Danielisová V., Gottlieb M., Kaplán P., Saniová B. (2009c): Ischemic tolerance: the mechanisms of neuropro-tective strategy. Anat Rec. (Hoboken). 292, 2002-2012 doi:10.1002/ar.20970
24. Matté C., Scherer E. B., Stefanello F. M., Barschak A. G., Vargas C. R., Netto C. A., Wyse A. T. (2007): Concurrent folate treatment prevents Na+,K+-ATPase activity inhibition and memory impairments caused by chronic hyperhomocysteinemia during rat development. Int J. Dev. Neurosci. 25, 545-552 doi:10.1016/j.ijdevneu.2007.10.003 (Pubitemid 350184247)
25. Mattson M. P., Kruman I. I., Duan W. (2002): Folic acid and homo-cysteine in age-related disease. Ageing Res. Rev. 1, 95-111 doi:10.1016/S0047-6374(01) 00365-7 (Pubitemid 38340354)
26. Michelangeli F., Ogunbayo O. A., Wootton L. L. (2005): A plethora of interacting organellar Ca2+ stores. Curr. Opin. Cell Biol. 17, 135-140 doi:10.1016/j.ceb.2005.01.005 (Pubitemid 40380936)
27. Mudd S. H., Levy H. L., Kraus J. P. (2001): Disorders of transsul-furation. In: Te Metabolic & Molecular Bases of Inherited Disease. (Eds. C.R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle), pp. 1279-1327, McGraw-Hill, New York
28. Murin R., Verleysdonk S., Raeymaekers R., Kaplan P., Lehotsky J. (2006): Distribution of secretory pathway Ca2+ ATPase (SPCA1) in neuronal and glial cell cultures. Cell. Mol. Neuro-biol. 26, 1355-1365 doi:10.1007/s10571-006-9042-z (Pubitemid 44924052)
29. Nenseter M. S., Ueland T., Retterstøl K., Strøm E., Mørkrid L., Lan-daas S., Ose L., Aukrust P., Holven K. B. (2009): Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect oftreatment with B-vitamins. Stroke 40, 241-247 doi:10.1161/STROKEAHA.108.522995
30. Obeid R., McCaddon A., Herrmann W. (2007): Te role ofhyper- homocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin. Chem. Lab. Med. 45, 1590-1606 doi:10.1515/CCLM.2007.356 (Pubitemid 350232981)
31. Obrenovitch T. P. (2008): Molecular physiology of preconditio-ning- induced brain tolerance to ischemia. Physiol. Rev. 88, 211-247 doi:10.1152/physrev.00039.2006
32. Pavlíková M., Tatarková Z., Sivoňová M., Kaplán P., Križanová O., Lehotský J. (2009): Alterations induced by ischemic preconditioning on secretory pathways Ca2 + -ATPase (SPCA) gene expression and oxidative damage after global cerebral ischemia/reperfusion in rats. Cell. Mol. Neurobiol. 29, 909-916 doi:10.1007/s10571-009-9374-6
33. Pignataro G., Scorziello A., Di Renzo G., Annunziato L. (2009): Post-ischemic brain damage: effect ofischemic preconditioning and postconditioning and identification ofpotential candidates for stroke therapy FEBS J. 276, 46-57 doi:10.1111/j.1742-4658.2008.06769.x
34. Prasad K. (1999): Homocysteine, a risk factor for cardiovascular disease. Int. J. Angiol. 8, 76-86 doi:10.1007/BF01616850 (Pubitemid 29057913)
35. Pulsinelli W. A., Brierley J. B., Plum F. (1982): Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11, 491-498 doi:10.1002/ana.410110509 (Pubitemid 12158810)
36. Refsum H., Ueland P. M., Nygard O., Vollset S. E. (1998): Homocyste-ine and cardiovascular disease. Annu Rev. Med. 49, 31-62 doi:10.1146/annurev.med.49. 1.31 (Pubitemid 28197439)
37. Robert K., Pagès C., Ledru A., Delabar J., Caboche J., Janel N.(2005): Regulation of extracellular signal-regulated kinase by homo-cysteine in hippocampus. Neuroscience 133, 925-935 doi:10.1016/j.neuroscience.2005.03.034 (Pubitemid 40814601)
38. Sepulveda M. R., Berrocal M., Marcos D., Wuytack F., Mata A. M. (2007): Functional and immunocytochemical evidence for the expression and localization of the secretory pathway Ca(2+)- -ATPase isoform 1 (SPCA1) in cerebellum relative to other Ca(2+)pumps. J. Neurochem. 103, 1009-1018 doi:10.1111/j.1471- 4159.2007.04794.x (Pubitemid 47568719)
39. Sepulveda M. R., Marcos D., Berrocal M., Raeymaekers L., Mata A. M., Wuytack F. (2008): Activity and localization of the secretory pathway Ca2+-ATPase isoform 1 (SPCA1) in different areas of the mouse brain during postnatal development. Mol. Cell. Neurosci. 38, 461-473 doi:10.1016/j.mcn.2008. 02.012
40. Seshadri S., Beiser A., Selhub J., Jacques P. F., Rosenberg I. H., D'Agostino R. B., Wilson P. W F., Wolf P. A. (2002): Plasma homocysteine as a risk factor for dementia and Alzheimers disease. N. Engl. J. Med. 346, 476-483 doi:10.1056/NEJMoa011613 (Pubitemid 34441738)
41. Signorello M. G., Pascale R., Leoncini G. (2002): Effect of homo-cysteine on arachidonic acid release in human platelets. Eur. J. Clin. Invest. 32, 279-284 doi:10.1046/j.1365-2362.2002.00971.x (Pubitemid 36216594)
42. Sivonová M., Kaplán P., Duracková Z., Dobrota D., Drgová A., Tatarková Z., Pavlíková M., Halasová E., Lehotský J. (2008): Time course of peripheral oxidative stress as consequence of global ischaemic brain injury in rats. Cell. Mol. Neurobiol. 28, 431-441 doi:10.1007/s10571-007-9246-x
43. Streck E. L., Vieira P. S., Matte C., Rombaldi F., Wannmacher C. M. D., Wajner M., Wyse A. T. S. (2002): Reduction of Na+,K+-ATPase activity in hippocampus of rats subjected to chemically-induced hyperhomocysteinemia. Neurochem. Res. 27, 1585-1590 doi:10.1023/A:1021670607647 (Pubitemid 36020111)
44. Tagliari B., Zamin L. L., Salbego C. G., Netto C. A., Wyse A. T. (2006): Homocysteine increases neuronal damage in hippo-campal slices receiving oxygen and glucose deprivation. Metab. Brain Dis. 21, 273-278 doi:10.1007/s11011-006- 9029-y (Pubitemid 46018232)
45. Taler R., Agsten M., Spitzer S., Paschalis E. P., Karlic H., Klaushofer K., Varga F. (2011): Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1 and epigenetic DNA-methylation. J. Biol. Chem. 286, 578-588 doi:10.1074/jbc.M110.166181
46. Tambyrajah J., Townend J. N. (2000): Homocysteine and athe- rothrombosis \- mechanisms for Injury. Europ. Heart. 21, 967-974 doi:10.1053/euhj.1999.1914 (Pubitemid 30312085)
47. Upchurch G. R. Jr., Welch G. N., Fabian A. J., Freedman J. E., John-son J. L., Keaney J. F. Jr., Loscalzo, J. (1997): Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272, 17007-17012
48. Urban P., Pavlíková M., Sivonová M., Kaplán P., Tatarková Z., Kaminska B., Lehotský J. (2009): Molecular analysis of endo-plasmic reticulum stress response afer global forebrain ische- mia/reperfusion in rats: effect ofneuroprotectant simvastatin. Cell. Mol. Neurobiol. 29, 181-192 doi:10.1007/s10571-008-9309-7
49. Uríková A., Babusíková E., Dobrota D., Drgová A., Kaplán P., Tatarková Z., Lehotský J. (2006): Impact of Ginkgo Biloba Extract EGb 761 on ischemia/reperfusion-induced oxidative stress products formation in rat forebrain. Cell. Mol. Neurobiol. 26, 1343-1353 (Pubitemid 44924051)
50. Van Baelen K., Dode L., Vanoevelen J., Callewaert G., De Smedt H., Missiaen L., Parys J. B., Raeymaekers L., Wuytack F. (2004): Te Ca2+/Mn2+ pumps in the Golgi apparatus. Biochim. Biophys. Acta 1742, 103-112 doi:10.1016/j.bbamcr.2004.08.018 (Pubitemid 39601770)
51. van den Berg M., van der Knaap M. S., Boers G. H., Stehouwer C. D., Rauwerda J. A., Valk J. (1995): Hyperhomocysteinaemia (with reference to its neuroradiological aspects). Neuroradi-ology 37, 403-411 doi:10.1007/ s002340050119
52. Vafai S. B., Stock J. B. (2002): Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease. FEBS Lett. 518, 1-4 doi:10.1016/S0014-5793(02)02702-3 (Pubitemid 34454953)
53. Wyse A. T., Zugno A. I., Streck E. L., Matté C., Calcagnotto T., Wannmacher C. M., Wajner M. (2002): Inhibition of Na(+),-K(+)-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem. Res. 27, 1685-1689 doi:10.1023/A:1021647329937 (Pubitemid 36020123)
54. Yenari M., Kitagawa K., Lyden P., Perez-Pinzon M. (2008): Me-tabolic downregulation: a key to successful neuroprotection? Stroke 39, 2910-2917 doi:10.1161/STROKEAHA.108.514471
55. Yilmaz E., Rüchan A., Serap T. E., Gülhis D., Yekbun A, Nejat A. (2010): Relationship between funnctional promoter polymorphism in the XBP1 gene (-116C/G) and atherosclerosis, ischemic stroke and hyperhomocysteinemia. Mol. Biol. Rep. 37, 269-272 doi:10.1007/s11033-009-9674-4
56. Zhang C. E., Wei W., Liu Y. H., Peng J. H., Tian Q., Liu G P., Zhang Y., Wang J. Z. (2009): Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am. J. Pathol. 174, 1481-1491 doi:10.2353/ajpath.2009.081036
57. Zieminska E., Lazarewicz J. W. (2006): Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors. Acta Neurobiol. Exp. (Wars). 66, 301-309 (Pubitemid 46114713)